Stanford-Backed Biotech Uses Bioneex AI to Scout Novel Brain-Penetrant Therapy
Finding the right drug candidate can take months, if not years, of painstaking research, outreach, and due diligence. But a Stanford professor–founded biotech may have just shown how much faster the process can move with AI.
